Toll-like receptor 3 (TLR3) activation induces microRNA-dependent reexpression of functional RARβ and tumor regression
Roberta Galli(Ospedale Filippo Del Ponte Varese), Carlo M. Croce(The Ohio State University), Muller Fabbri(The University of Texas MD Anderson Cancer Center), Luciano Cascione(Institute of Oncology Research), Francesca Lovat(Cancer Genetics (United States)), Nicola Zanesi, Anna Riccioli(Istituto Pasteur), Stefano Volinia(University of Ferrara), Federica Calore(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Antonio Filippini(Università Campus Bio-Medico), Alessio Paone(Istituto Pasteur), Elio Ziparo(Sapienza University of Rome), Andrea Tubaro(Sapienza University of Rome), Pierluigi Gasparini(The Ohio State University), Antonella Stoppacciaro(Sapienza University of Rome), Mario Acunzo(Libera Università Maria SS. Assunta), Paolo Fadda(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Hansjüerg Alder(The Ohio State University)
Cited by 58
Related Papers
The role of MicroRNAs in human cancer
|Signal Transduction and Targeted Therapy|2016|2.5k
MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon Adenocarcinoma
|JAMA|2008|1.6k
MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response
|Proceedings of the National Academy of Sciences|2012|1.5k
MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias
|Proceedings of the National Academy of Sciences|2004|1.3k
MicroRNA Expression Abnormalities in Pancreatic Endocrine and Acinar Tumors Are Associated With Distinctive Pathologic Features and Clinical Behavior
|Journal of Clinical Oncology|2006|778